Effects of Intraduodenal Infusion of the Bitter Tastant, Quinine, on Antropyloroduodenal Motility, Plasma Cholecystokinin, and Energy Intake in Healthy Men.

Conclusion: Quinine, administered intraduodenally over 60 minutes, even at moderately high doses, but low infusion rates, does not modulate appetite-related gastrointestinal functions or energy intake. PMID: 31177650 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31177650?dopt=Abstract

Source: Journal of Neurogastroenterology and Motility - June 12, 2019 Category: Gastroenterology Tags: J Neurogastroenterol Motil Source Type: research